Skip to content
Screener

Upstream Bio, Inc. UPB Interest Income

Interest Income at other companies

Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$1.76M-12.7%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$1.03M+28.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$2.65M-39.9%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$3.65M-38.4%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$8.74M+11.5%
Roivant Sciences logo
Roivant SciencesROIV
$36.92M-23.6%

Other financials

Income statement

See full
Revenue$773.0K-17.5%
Operating income-$42.4M+4.5%
Net income-$39.7M+0.7%
EPS (diluted)-$0.73+1.4%

Balance sheet

See full
Cash & equivalents$79.4M+74.7%
Total debt$954.0K-38.9%
Total equity$271.0M-33.7%
Total assets$281.2M-33.1%

Cash flow

See full
Operating cash flow-$35.6M+9.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$394.54M-54.7%
Enterprise value$316.1M-61.6%
P/S124.9×-195×

Profitability

See full
Operating margin-5,382.6%+1,393pp
Net margin-4,955.7%+2,041pp

Returns & leverage

See full
Return on equity-46%
Debt / equity0.0×
Current ratio28×-10.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 7:10 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-343417
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total operating expenses43,14145,28487,79077,863
Loss from operations(42,368)(44,347)(85,983)(76,360)
Other income (expense):
Interest income2,6594,4315,7139,174
Other income (expense), net7(50)(23)(50)
Total other income, net2,6664,3815,6909,124
Net loss$(39,702)$(39,966)$(80,293)$(67,236)
Net loss per share attributable to common stockholders, basic and diluted$(0.73)$(0.74)$(1.47)$(1.25)

Item 1. Financial Statements.

FAQ

What is Upstream Bio, Inc.'s interest income?
Upstream Bio, Inc. (UPB) reported interest income of $2.66M in Q2 2026.
How has Upstream Bio, Inc.'s interest income changed year-over-year?
Upstream Bio, Inc.'s interest income decreased by 40.0% year-over-year, from $4.43M to $2.66M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Upstream Bio, Inc.'s interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude